Growth Metrics

Veon (VEON) Asset Writedowns and Impairment (2016 - 2024)

Veon has reported Asset Writedowns and Impairment over the past 14 years, most recently at -$1.0 million for Q2 2024.

  • For Q2 2024, Asset Writedowns and Impairment fell 114.29% year-over-year to -$1.0 million; the TTM value through Jun 2024 reached -$41.0 million, down 412.5%, while the annual FY2025 figure was $9.0 million, 200.0% up from the prior year.
  • Asset Writedowns and Impairment was -$1.0 million for Q2 2024 at Veon, down from $7.0 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $64.0 million in Q3 2020 and bottomed at -$34.0 million in Q4 2022.
  • The 5-year median for Asset Writedowns and Impairment is -$1.0 million (2020), against an average of $4.4 million.
  • Year-over-year, Asset Writedowns and Impairment soared 3300.0% in 2021 and then plummeted 333.33% in 2022.
  • Over 5 years, Asset Writedowns and Impairment stood at -$1.0 million in 2020, then soared by 3300.0% to $32.0 million in 2021, then crashed by 206.25% to -$34.0 million in 2022, then surged by 120.59% to $7.0 million in 2023, then tumbled by 114.29% to -$1.0 million in 2024.
  • The last three reported values for Asset Writedowns and Impairment were -$1.0 million (Q2 2024), $7.0 million (Q2 2023), and -$34.0 million (Q4 2022) per Business Quant data.